Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mary Young Lowry

Pediatric Gastroenterology Flowood, MS Medical Doctor

NPI 1285952465 CMS profile 2336832

2510 Lakeland Dr, Flowood, MS 39232

Open in the dashboard

General payments

$4,800

111 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$39,454

4 holdings reported · through program year 2025

Research they led as principal investigator

$151,670 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Mary Young Lowry of Flowood, MS is reported in the CMS Open Payments database as having received $4,800 across 111 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $151,670 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $39,454 across 4 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 83rd percentile of Pediatric Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $451 17
2024 General $2,849 19
2023 General $186 6
2022 General $443 20
2021 General $308 18
2020 General $183 11
2019 General $380 20
2024 Ownership $19,410 1
2023 Ownership $19,410 1
2022 Ownership $318 1
2021 Ownership $316 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mary Young Lowry
  • Pediatric Gastroenterology median
  • Middle half of Pediatric Gastroenterology
  • National median

In program year 2025, general payments to Mary Young Lowry were reported at $451. Among 1,132 Pediatric Gastroenterology profiles paid that year, the median was $194 and the middle half received between $81 and $540.

Show as a table
Year Mary Young Lowry Pediatric Gastroenterology median Middle half National median
2019 $380 $131 $41–$311 $163
2020 $183 $79 $23–$223 $114
2021 $308 $104 $32–$321 $132
2022 $443 $125 $37–$331 $149
2023 $186 $169 $55–$440 $160
2024 $2,849 $196 $73–$563 $164
2025 $451 $194 $81–$540 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Regeneron Pharmaceuticals, Inc. $2,564 4 payments
  2. AbbVie, Inc. $619 33 payments
  3. Salix Pharmaceuticals, a division of Bausch Health US, LLC $295 18 payments
  4. QOL Medical, LLC $239 9 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $185 10 payments
  6. Janssen Biotech, Inc. $168 5 payments
  7. Genzyme Corporation $151 5 payments
  8. Alexion Pharmaceuticals, Inc. $82 2 payments
  9. Phathom Pharmaceuticals, Inc. $81 3 payments
  10. Ipsen Biopharmaceuticals, Inc $71 4 payments
  11. Other $344 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $2,412 2 payments
  2. Food and Beverage $2,304 108 payments
  3. Education $84 1 payment
Products named General payments · program years 2019–2025
  1. DUPIXENT Inflammation And Immunology $2,599 6 payments
  2. HUMIRA $449 25 payments
  3. XIFAXAN $220 13 payments
  4. Sucraid $176 6 payments
  5. TREMFYA $168 5 payments
  6. DUPIXENT Immunology $151 5 payments
  7. ENTYVIO $109 6 payments
  8. VOQUEZNA $81 3 payments
  9. CREON $72 4 payments
  10. IQIRVO $71 4 payments
  11. Other $586 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

111 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Gastroenterology in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record